Metabolon is a biotechnology company that specializes in metabolomics, a field of study that involves the measurement of small molecules in biological samples. The company's technology platform can be used to identify biomarkers for a variety of diseases, including cancer, diabetes, and neurological disorders. Metabolon also offers diagnostic tests and research services to pharmaceutical and biotechnology companies. The company was founded in 2000 and is headquartered in Durham, North Carolina.